Skip to content

Efficacy check of hair care products

To evaluate & compare the in-vivo safety and efficacy of Hair care formulation Vs Regime in terms of reduction in hair fall on healthy human subjects. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060610
Enrollment
72
Registered
2023-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Shampoo: Apply approximately 3 to 5 ml shampoo (depending on the length of hair) to wet hair and scalp. Generate sufficient lather on scalp and hair by massaging for at least 30 seconds

Sponsors

SATIYA NUTRACEUTICALS PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian male & female subjects. 2)Healthy subjects 3)Skin & scalp is healthy on the studied anatomic unit 4) Having moderate to severe hair fall

Exclusion criteria

Exclusion criteria: 1)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 2) Having a progressive asthma (either under treatment or last fit in the last 2 years) 3) Being epileptic 4) Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 5) Having cutaneous hypersensitivity 6) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products 7) Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 8) Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months 9) Having changed his/her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit. 10) Having applied a hair care product and cosmetic product on the studied area as well as on the face the first day of the study (except the neutral shampoo without anti hairfall claim or hair growth claim) 11)Having naturally fair or white hair (Which will interfere the evaluation) 12)Having a dermatosis on the scalp 13)Having surgery history on the scalp (micro transplants) 14)Refusing the bleaching of two areas of the scalp of approx. 40 hairs, the first day of the study. 15)Refusing the pluking of approx. 10 hairs, during the entire study 16)Having presented a factor inducing a telogen effluvium in the 3 months preceding the start of the study (delivery, important stress, high fever)

Design outcomes

Primary

MeasureTime frame
Reduction in hair fallTimepoint: Baseline, 14 days, 28 days

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026